WallStreetZenWallStreetZen

NASDAQ: NEPH
Nephros Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Nephros earnings were $1.2M for the trailing 12 months ending Dec 31, 2025, with 1,000% growth year over year. The latest NEPH earnings report on Dec 31, 2025 announced Q4 2025 earnings of $62.0k, down 81.6% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, NEPH reported annual earnings of $1.2M, with 1,513.5% growth. The next NEPH earnings date is May 13, 2026.

NEPH past earnings growth

How has NEPH's earnings growth performed historically?

Company
1,000%
Industry
9.88%
Market
86.1%
NEPH's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
NEPH's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Market Performance
NEPH's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

NEPH earnings history

Current Revenue
$18.8M
Current Earnings
$1.2M
Current Profit Margin
6.4%

NEPH Return on Equity

Current Company
12.2%
Current Industry
10.5%
Current Market
29.6%
NEPH's Return on Equity (12.2%)... subscribe to Premium to read more.
High Return on Equity Performance

NEPH Return on Assets

Current Company
9.4%
Current Industry
8.3%
NEPH is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when NEPH announces earnings.

NEPH Return on Capital Employed

Current Company
11.1%
Current Industry
9.3%
NEPH has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

NEPH vs Medical Stocks

TickerEBITDAEarningsY/Y EarningsEPS
NEPH$1.35M$1.19M+1,000.00%$0.11
EKSO-$9.81M-$11.70MN/A-$4.91
FEMY-$17.01M-$19.80MN/A-$0.72
POCI-$6.31M-$6.92MN/A-$0.92
MLSS-$6.48M-$6.67MN/A-$0.08
View Top Medical Stocks

NEPH earnings dates

Next earnings date
May 13, 2026

Nephros Earnings Reports & History FAQ

What were Nephros's earnings last quarter?

On NEPH's earnings call on Invalid Date, Nephros (NASDAQ: NEPH) reported Q4 2025 earnings per share (EPS) of $0.00, up 100% year over year. Total NEPH earnings for the quarter were $62.00 thousand. In the same quarter last year, Nephros's earnings per share (EPS) was $0.04.

If you're new to stock investing, here's how to buy Nephros stock.

When does Nephros report earnings?

The next NEPH earnings date is Invalid Date. Add NEPH to your watchlist to be reminded of Nephros's next earnings date.

Is Nephros profitable or losing money?

As of the last Nephros earnings report, Nephros is currently profitable. Nephros's net profit (also called net income) for the twelve months ending Dec 31, 2025 was $1.19 million, a 1,513.51% increase year over year.

What was NEPH's earnings growth in the past year?

As of Nephros's earnings date in Invalid Date, Nephros's earnings has grown 1,000% year over year. This is 990.12 percentage points higher than the US Medical Instruments & Supplies industry earnings growth rate of 9.88%. NEPH earnings in the past year totalled $1.19 million.

What are Nephros's earnings expectations?

The current EPS estimate for Nephros's earnings report in Invalid Date is $0.04.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.